Bibliographic Details
| Title: |
Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes. |
| Authors: |
Genzano, Camillo Bechi, Bezzecchi, Eugenia, Carnovale, Debora, Mandelli, Alessandra, Morotti, Elisa, Castorani, Valeria, Favalli, Valeria, Stabilini, Angela, Insalaco, Vittoria, Ragogna, Francesca, Codazzi, Valentina, Scotti, Giulia Maria, Del Rosso, Stefania, Mazzi, Benedetta Allegra, De Pellegrin, Maurizio, Giustina, Andrea, Piemonti, Lorenzo, Bosi, Emanuele, Battaglia, Manuela, Morelli, Marco J. |
| Source: |
Frontiers in Immunology; 10/28/2022, Vol. 13, p1-13, 13p |
| Subject Terms: |
TYPE 1 diabetes, FLOW cytometry, REGULATORY T cells, DELAYED onset of disease, AUTOIMMUNE thyroiditis, T cells |
| Abstract: |
An unbiased and replicable profiling of type 1 diabetes (T1D)-specific circulating immunome at disease onset has yet to be identified due to experimental and patient selection limitations. Multicolor flow cytometry was performed on whole blood from a pediatric cohort of 107 patients with new-onset T1D, 85 relatives of T1D patients with 0-1 islet autoantibodies (pre-T1D_LR), 58 patients with celiac disease or autoimmune thyroiditis (CD_THY) and 76 healthy controls (HC). Unsupervised clustering of flow cytometry data, validated by a semi-automated gating strategy, confirmed previous findings showing selective increase of naïve CD4 T cells and plasmacytoid DCs, and revealed a decrease in CD56brightNK cells in T1D. Furthermore, a non-selective decrease of CD3+CD56+ regulatory T cells was observed in T1D. The frequency of naïve CD4 T cells at disease onset was associated with partial remission, while it was found unaltered in the pre-symptomatic stages of the disease. Thanks to a broad cohort of pediatric individuals and the implementation of unbiased approaches for the analysis of flow cytometry data, here we determined the circulating immune fingerprint of newly diagnosed pediatric T1D and provide a reference dataset to be exploited for validation or discovery purposes to unravel the pathogenesis of T1D. [ABSTRACT FROM AUTHOR] |
|
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
